Skip to main content
TipRanks
Go Ultimate75% OFF

Mineralys Therapeutics, Inc. (MLYS) Balance Sheet

614 Followers

Mineralys Therapeutics, Inc. Balance Sheet

Mineralys Therapeutics, Inc.'s total assets for Q3 2026 were $630.12M, a decrease of 5.65% from the previous quarter. MLYS total liabilities were $126.35M for the fiscal quarter, a 8.05% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 661.81M$ 205.90M$ 251.64M$ 114.44M$ 11.13M
$ 15.11M$ 14.65M$ 10.48M$ 166.71M$ 34.05M
$ 646.69M$ 191.26M$ 241.15M$ -52.27M$ -22.93M

Currency in USD

Mineralys Therapeutics, Inc. Liabilities to Assets

0250M500M750M0 %120 %240 %360 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets